IntelligentMDx featured in the November issue of IVD Technology Magazine
Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx talks to Richard Park, Editor of IVD Technology Magazine In Person: Trends and Advances in Molecular Diagnostics. Click here to read the article.
IntelligentMDx is a commercial stage molecular diagnostics company that makes tests that are clinically impactful, competitively differentiated, and platform agnostic. We have product offerings for Seasonal/Pandemic Influenza, Bordetella, Transplantation and Infection Control including antimicrobial resistance screening. IntelligentMDx commercializes molecular diagnostic test solutions under FDA QSR, ISO 13485:2003 and IVDD regulations and guidances for use in clinical reference laboratories. IntelligentMDx test solutions are designed to be clinically impactful, competitively differentiated, and platform-agnostic.